
Merck’s diabetes drug Januvia has been given a boost following worries over side effects for patients after a trial revealed …
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics

